Affinia Therapeutics

OverviewSuggest Edit

Affinia Therapeutics is a biotech company. It develops transformative gene therapies for devastating diseases.
TypePrivate
Founded2019
Websiteaffiniatx.com

Latest Updates

Employees (est.) (Oct 2020)30(+4%)
Cybersecurity ratingBMore

Affinia Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2019

Affinia Therapeutics total Funding

$60 m

Affinia Therapeutics latest funding size

$60 m

Time since last funding

7 months ago

Affinia Therapeutics investors

Affinia Therapeutics's latest funding round in March 2020 was reported to be $60 m. In total, Affinia Therapeutics has raised $60 m
Show all financial metrics

Affinia Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Affinia Therapeutics Online and Social Media Presence

Embed Graph

Affinia Therapeutics Frequently Asked Questions

  • When was Affinia Therapeutics founded?

    Affinia Therapeutics was founded in 2019.

  • How many employees does Affinia Therapeutics have?

    Affinia Therapeutics has 30 employees.

  • Who are Affinia Therapeutics competitors?

    Competitors of Affinia Therapeutics include MicrofluidX, Stealth BioTherapeutics and CAMP4 Therapeutics.